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I only have some minor comments: It is not totally clear to me how the GP and ENT were purposefully chosen. Maybe an exact description of inclusion/exclusion criteria would help It is also not totally clear to me what the training status of the interviewers is. Is the first author MD? PhD (I presume yes seeing dr. but probably not so clear to non Dutch). Psychologist? Any knowledge on CRS?
Can the authors explain what local prescribing restrictions mean? Does that mean that you cannot prescribe a modern ICNS (e.g. fluticasone) but you can an older one (e.g. beconase). Or does that mean that the GP cannot prescribe an ICNS at all?
It might be worthwhile putting the work a little bit more in perspective of other literature on the same subject. See refs below but others might exist.
Hoffmans R, Schermer T, van 
Please leave your comments for the authors below
This semi-structured qualitative telephone interview showed that GPs describe themselves as confident in recognizing CRS, with the exception of assessing nasal polyps, whereas specialists report common missed diagnoses. Steroid nasal sprays provide basic in primary care and poor adherence is perceived to be the causes of inadequate symptom control. Inadequate disease control, and patient pressure drive referral. In secondary care surgery is regarded as an important treatment option for patients with severe disease, although timing of surgery remains unclear.
The study is important to show that there is uncertainty about best management of patients with CRS in both primary and secondary care and practice is varied. Thus improved care pathway is needed.
There are some concerns.
1) The major concern is that the difference of the populations might be a confounding factor when observing the differences of responses between GPs and ENT specialists. Otorhinolaryngologists and GPs see different CRS patients. This might affect their opinion on easiness or difficulties of CRS diagnosis and treatment. If possible, please consider to provide additional data of GPs responses separately of their "general CRS population" and of their "CRS population who get referral to Otorhinolaryngologist". If this data is not available, please consider to discuss this as a limitation. 3) The information given in the Appendix 1 is not fully clear. Please consider to clarify it and to provide online supplement data of the questions and responses. Please consider also to provide Supplementary data of methods how the opinions of GP group and ENT group were drawn and generalized that are presented in the results section. 
GENERAL COMMENTS
The reviewer completed the checklist but made no further comments.
